← FDA Drug Approvals (Drugs@FDA)
L-GLUTAMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RENOVA PHARMS · Approved 2026-05-14
Drug application
- FDA Application #
ANDA219750- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- L-GLUTAMINE
- Generic name
- L-GLUTAMINE
- Active ingredients
- L-GLUTAMINE
- Dosage form
- FOR SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RENOVA PHARMS
- Manufacturer
- Renova Pharmaceuticals LLC
- First approval
- 2026-05-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown